MONTREAL, Sept. 1, 2026 — Scopia Surgical, a Montreal-based TechMed company developing real-time AI-powered surgical navigation for minimally invasive and robotic surgery, has closed an oversubscribed $2.65M CAD pre-seed financing round co‑led by Linearis Ventures and Anges Québec. Participation included Fonds Impulsion, an initiative of the Government of Quebec managed by Investissement Québec, HaloHealth, Richard Rubin, Suresh Madan, and other investors.
“This round, backed by investors who have built and scaled life sciences companies, gives us the resources and expert advisory needed to bring our vision into the first clinical evaluations”, said Gabriel Rivest, CEO and co-founder.
The company said the proceeds will be used to grow engineering and clinical teams, accelerate product development, and advance the first clinical validation of Scopia Surgical Navigation across several hospitals in Canada and the United States. “Our goal is to bring the full richness of preoperative imaging into the operating room, in real time on the systems hospitals already own to reduce complications and optimize surgical outcomes”, Rivest added.
“The momentum behind this oversubscribed financing reflects our confidence in Scopia’s vision and its ability to unlock the transformative potential of physical AI within one of healthcare’s fastest-growing markets. We believe Scopia could become a category-defining company”, said Manon Boisclair, Managing Partner, Linearis Ventures.
“Scopia Surgical captured the attention of the Angels through its potential to optimize surgeons’ practice with an innovative solution compatible with current operating room equipment. We are extremely proud to support these forward-thinking entrepreneurs”, said Hélène Moore, Anges Québec Representative.
Scopia Surgical technology and clinical roadmap
Scopia Surgical is building a physical AI software platform for robotic surgery. By fusing real-time spatial intelligence with patient-specific digital twins, the company aims to bridge the gap between human intervention and robotic execution. The technology, based on computer vision, is designed to enable existing systems to achieve higher precision and to transform the operating room into a high-fidelity, autonomous-ready environment.
About Scopia Surgical
Scopia Surgical is developing real-time AI-powered surgical navigation for minimally invasive and robotic surgery. For more information, visit www.scopia.tech
About Linearis Ventures
Linearis, with its tandem Ventures Fund and Laboratory, invests in AI-powered life sciences companies focused on preventing, detecting and curing diseases. To learn more, visit www.linearis.com
About Anges Québec
Anges Québec is Canada’s largest angel investor network, with more than $200M CAD invested since 2008 and over 115 active companies in its portfolio. For more information, visit www.angesquebec.com
